13G Filing: James E. Flynn and Proteon Therapeutics Inc (PRTO)

Page 8 of 19

Page 8 of 19 – SEC Filing

CUSIP No.

74371L109

13G Page 8
of 15 Pages
1.

NAME OF REPORTING PERSONS

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

Deerfield Private Design Fund III, L.P.

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)

(b) ☒

3.

SEC USE ONLY

4.

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

 

 

 NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

5.

SOLE VOTING POWER

0

6.

SHARED VOTING POWER

877,799

7.

SOLE DISPOSITIVE POWER

0

8.

SHARED DISPOSITIVE POWER

877,799

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

877,799

10.

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES*

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

5.23%

12.

TYPE OF REPORTING PERSON*

PN

Follow Protara Therapeutics Inc. (NASDAQ:TARA)

Page 8 of 19